Iliac Stent Market Report 2026
Global Outlook – By Type (Self-Expandable Stents, Balloon-Expandable Stents, Other Types), By Artery Lesions (Common Iliac Artery Lesions, Severe Calcified Lesions), By End-Users (Hospitals, Outpatient Facilities, Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2030
Iliac Stent Market Overview
• Iliac Stent market size has reached to $1.09 billion in 2025 • Expected to grow to $1.5 billion in 2030 at a compound annual growth rate (CAGR) of 6.4% • Growth Driver: Rising Prevalence of Peripheral Artery Diseases Fuels The Iliac Stent Market • Market Trend: Advancements In Iliac Stent Technologies With FDA Approval Enhances Safety, Innovation, and Accessibility • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Iliac Stent Market?
Iliac stents are specialized medical devices designed to treat atherosclerosis in the iliac arteries, which are located in the pelvic region. These stents are deployed through minimally invasive procedures such as angioplasty to expand and support narrowed or blocked arteries. The main types of iliac stents are self-expandable stents, balloon-expandable stents, and others. Self-expandable stents are medical devices used to treat narrowed or blocked blood vessels in various parts of the body, such as the coronary arteries, peripheral arteries, and other tubular structures. The various artery lesions include common iliac artery lesions, severe calcified lesions, and complete obstructive lesions used by various end-users such as hospitals, outpatient facilities, and others.
What Is The Iliac Stent Market Size and Share 2026?
The iliac stent market size has grown strongly in recent years. It will grow from $1.09 billion in 2025 to $1.17 billion in 2026 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to rising prevalence of peripheral artery disease, growing aging population, increased adoption of endovascular procedures, expansion of hospital-based vascular care, improved diagnosis of iliac artery lesions.What Is The Iliac Stent Market Growth Forecast?
The iliac stent market size is expected to see strong growth in the next few years. It will grow to $1.5 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to growing demand for minimally invasive treatments, increasing incidence of lifestyle-related vascular disorders, expanding access to interventional cardiology services, rising healthcare expenditure in emerging economies, increasing focus on early vascular intervention. Major trends in the forecast period include rising adoption of minimally invasive peripheral interventions, increasing preference for self-expandable iliac stents, growing use of drug-eluting and covered stents in complex lesions, shift toward outpatient and day-care endovascular procedures, expansion of iliac stent usage in severe and calcified lesions.
Global Iliac Stent Market Segmentation
1) By Type: Self-Expandable Stents, Balloon-Expandable Stents, Other Types 2) By Artery Lesions: Common Iliac Artery Lesions, Severe Calcified Lesions 3) By End-Users: Hospitals, Outpatient Facilities, Other End-Users Subsegments: 1) By Self-Expandable Stents: Nitinol Self-Expandable Stents, Polymer-Coated Self-Expandable Stents 2) By Balloon-Expandable Stents: Bare-Metal Balloon-Expandable Stents, Drug-Eluting Balloon-Expandable Stents 3) By Other Types: Covered Stents, Hybrid StentsWhat Is The Driver Of The Iliac Stent Market?
The increasing prevalence of peripheral artery diseases is expected to propel the growth of the iliac stent market going forward. Peripheral artery disease (PAD) is a circulatory condition characterized by the narrowing or blockage of arteries outside the heart and brain. The increasing prevalence of peripheral artery diseases is due to smoking, the aging population, hypertension, and diabetes. Iliac stenting is an effective treatment option for patients with PAD, offering improved blood flow, symptom relief, and prevention of complications while also being minimally invasive and associated with a high success rate. For instance, in July 2023, according to the Society For Cardiovascular Angiography And Interventions, a US-based organization, PAD affects 8-10 million Americans each year, and it is estimated that 19 million Americans will have PAD by 2050. Therefore, the increasing prevalence of peripheral artery diseases drives the iliac stent industry.Key Players In The Global Iliac Stent Market
Major companies operating in the iliac stent market are Cardinal Health Inc., Abbott Laboratories, Medtronic Plc, Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, W. L. Gore & Associates Inc, C. R. Bard Inc., Getinge AB, Cook Medical LLC, Biotronik SE & Co. KG, MicroPort Scientific Corporation, Cordis Corporation, Endologix Inc., LeMaitre Vascular Inc., Alvimedica, Clearstream Technologies Ltd., Jotec GmbH, Translumina GmbH, Vascular Concepts Limited, Lombard Medical Technologies, Acandis GmbH, Gore Medical, Medizintechnik GmbH
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.
This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Explore how leading companies compare across key metrics in our report Get Report
Global Iliac Stent Market Trends and Insights
Major companies operating in the iliac stent market are developing innovative products such as iCast to improve patient outcomes and reduce the risk of complications. iCast-covered stent system represents an innovative approach to treating iliac artery occlusive disease, offering improved performance and reduced risk of complications compared to traditional bare-metal stents. For instance, in October 2023, Getinge, a Sweden-based healthcare company, announced the commercial availability of the iCast-covered stent system in the USA for treating iliac arterial occlusive disease approved by the Food and Drug Administration (FDA). This indication reflects Getinge's commitment to bringing high-quality products and support to US clinicians and hospital systems to treat this severe condition.What Are Latest Mergers And Acquisitions In The Iliac Stent Market?
In February 2023, Abbott Laboratories, a US-based pharmaceutical company, acquired Cardiovascular Systems Inc. (CSI) for an undisclosed amount. With this acquisition, Abbott Laboratories aims to enhance its vascular device offerings by integrating CSI's innovative atherectomy system into its portfolio. Cardiovascular Systems Inc. is a US-based medical technology company that manufactures iliac stents.
Regional Outlook
North America was the largest region in the iliac stent market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainNeed data for a specific geography? Request Regional Data
What Defines the Iliac Stent Market?
The iliac stents market consists of sales of coronary stents, biliary stents, and ureteral stents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.
This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
Access full TAM calculations and growth projections in our report Get Report
What Key Data and Analysis Are Included in the Iliac Stent Market Report 2026?
The iliac stent market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the iliac stent industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Iliac Stent Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $1.17 billion |
| Revenue Forecast In 2030 | $1.5 billion |
| Growth Rate | CAGR of 6.4% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Type, Artery Lesions, End-Users |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Cardinal Health Inc., Abbott Laboratories, Medtronic Plc, Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, W. L. Gore & Associates Inc, C. R. Bard Inc., Getinge AB, Cook Medical LLC, Biotronik SE & Co. KG, MicroPort Scientific Corporation, Cordis Corporation, Endologix Inc., LeMaitre Vascular Inc., Alvimedica, Clearstream Technologies Ltd., Jotec GmbH, Translumina GmbH, Vascular Concepts Limited, Lombard Medical Technologies, Acandis GmbH, Gore Medical, Medizintechnik GmbH |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |